Galapagos NV
GLPG
#4569
Rank
โ‚น196.82 B
Marketcap
โ‚น2,987
Share price
0.36%
Change (1 day)
42.97%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -โ‚น34.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น30.59. In 2024 the company made an earnings per share (EPS) of โ‚น105.14 a decrease over its 2023 EPS that were of โ‚น320.12.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น34.67-132.97%
2024โ‚น105.14-67.16%
2023โ‚น320.12-199.64%
2022-โ‚น321.2799.03%
2021-โ‚น161.42-68.98%
2020-โ‚น520.40-298.06%
2019โ‚น262.75-554.64%
2018-โ‚น57.79-77.18%
2017-โ‚น253.28-326.21%
2016โ‚น111.97-134.19%
2015-โ‚น327.47-371.34%
2014โ‚น120.69-445.98%
2013-โ‚น34.8832.88%
2012-โ‚น26.25-82.07%
2011-โ‚น146.44-817.9%
2010โ‚น20.4012.73%
2009โ‚น18.09-120.79%
2008-โ‚น87.02-37.67%
2007-โ‚น139.6239.64%
2006-โ‚น99.9928.17%
2005-โ‚น78.016.25%
2004-โ‚น73.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
โ‚น273.79-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น941.75-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น334.29-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚น121.95-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-โ‚น55.03 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น726.83-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น56.83-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น324.39-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น685.04-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA